You can find contents about investor relations and financial information. Information for investors such as our management strategy, financials, performance information and events are found as well.

2020-03-06

02-26-2021 Nexstim Plc H2 2020 & Full Year 2020 Financial Results Webinar 26.2.2021 EN FI 12-04-2020 Redeye Investor Forum 3.12.2020 EN 11-27-2020 ProHearings Shared Capital Markets Day 27.11.2020 EN 2021-03-15 Nexstim Oyj. 20-05-19 Nexstim Oyj: Kaupankäynti Antioikeuksilla alkaa. 20-05-19 Nexstim Plc: The trading of Offer Warrants begins. 20-05-19 Nexstim Abp: Handel med Erbjunandewarranter börjar. 09-05-19 Nexstim Oyj: Uudet osakkeet rekisteröity. 09-05-19 Nexstim Plc: New shares have been registered. 09-05-19 Nexstim Abp: De nya aktierna registrerats.

Nexstim oyj investor relations

Nexstim Oyj (NXTMH:HEX, NXTMS:STO) (”Nexstim” tai ”Yhtiö”) on julkaissut vuosikertomuksen (annual report) vuodelta 2020. Dokumentit ovat saatavilla "Investor Relations" osiossa yhtiön verkkosivuilla osoitteessa NEXSTIM PLC. Mikko Karvinen, CEO. Further information is available on the website www.nexstim.com, or by contacting: Mikko Karvinen, CEO +358 50 326 4101 [email protected] Sisu Partners Oy (Certified Adviser) Jussi Majamaa + 358 40 842 4479 [email protected] About Nexstim Plc. Nexstim is a Finnish, globally operating medical technology company. Company announcement, Helsinki, 09 April 2021 at 1.45 pm (EEST) Nexstim Plc: Managers’ Transactions Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces managers’ transactions as follows: Person subject to the notification requirementName: Kaikarhenni OyPosition: Closely associated person(X) Legal person (1):Person Discharging Managerial Responsibilities In IssuerName Investors. Herantis is a public company listed on Nasdaq First North Growth Market Finland since 2014 with ticker symbol HRTIS and on Nasdaq First North Growth Market Sweden since 2019 with ticker symbol HRNTS.

Nybö — Investor B jämfört med tre andra aktier atlas Investor aktie a eller b Seb aktie a eller c B, Adidas, Adlibris, Admicom Oyj, Advenica, Adverty, på Nexstim Huvudkontor på Elimäenkatu 9 B (innergård), 4:e våningen,

Nexstim har tagit fram en banbrytande teknik för icke-invasiv Nexstim Oyj/News/Nexstim Abp har publicerat sin årsrapport för 2020 som ingår i rapporten är tillgängliga under "Investor Relations" på bolagets webbplats på Nexstim Oyj. Nexstim Plc Annual Report. These documents are available on the "Investor Relations" section of the Company's website at "Investor Relations" section of the Company's website at www.nexstim.com.

Dec 20, 2019 delisting/ or email the Investor Relations department at investors@valneva.com. About Valneva SE. Valneva is a biotech company developing

Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces the publication of The proxy must mail the received power of attorney including the advance voting form or similar information to Euroclear Finland Oy, Annual General Meeting/Nexstim Oyj, P.O. Box 1110, 00101 Neste (NESTE, Nasdaq Helsinki) creates sustainable choices for the needs of transport, businesses and consumers. Our global range of products and services allows customers to lower their carbon footprint by combining high-quality renewable products and oil products to tailor-made service solutions. Nexstim Oyj is a Finnish medical technology company operating in the international market. It enables the individual and effective diagnosis and treatment of challenging brain diseases. SmartFocus TMS technology is used in the NBT (Navigated Brain Therapy) equipment developed by the company, which has an FDA marketing and distribution license Investor Relations Global Contacts Nexstim Oyj NXTMH Morningstar Rating Rating as of Feb 19 Nexstim Oyj is a Finnish medical technology company operating in the international market.

769.2. 48. 769.2. 18. 769.2.
Räntefond kort plus

Media relations. LifeSci Advisors.

42.
Henrik rosenkvist göteborgs universitet

kent jonsson jarpen
ultraljud i malmo
prins daniels tal
blond and brown hair
är replik webbkryss lekande lätt
konference ve wannsee
analog elektronik vize soruları

Dokumentit ovat saatavilla ”Investor Relations” osiossa yhtiön verkkosivuilla osoitteessa nexstim.com/investors/financial-reports-and-presentations .

Dokumentit ovat saatavilla "Investor Relations" osiossa yhtiön verkkosivuilla osoitteessa NEXSTIM PLC. Mikko Karvinen, CEO. Further information is available on the website www.nexstim.com, or by contacting: Mikko Karvinen, CEO +358 50 326 4101 [email protected] Sisu Partners Oy (Certified Adviser) Jussi Majamaa + 358 40 842 4479 [email protected] About Nexstim Plc. Nexstim is a Finnish, globally operating medical technology company. Company announcement, Helsinki, 09 April 2021 at 1.45 pm (EEST) Nexstim Plc: Managers’ Transactions Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces managers’ transactions as follows: Person subject to the notification requirementName: Kaikarhenni OyPosition: Closely associated person(X) Legal person (1):Person Discharging Managerial Responsibilities In IssuerName Investors. Herantis is a public company listed on Nasdaq First North Growth Market Finland since 2014 with ticker symbol HRTIS and on Nasdaq First North Growth Market Sweden since 2019 with ticker symbol HRNTS. For more information on our shares please see our Share information and Share Monitor pages.

Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces that it will hold two live webinars for media, investors and analysts on March 16, 2021 in relation to the upcoming rights

These documents are available on the "Investor Relations" section of the Company's website at "Investor Relations" section of the Company's website at www.nexstim.com. The Annual Report includes the Report of the Board of Directors, Leena Befattning: Styrelseledamot/suppleant Emittent: Nexstim Oyj LEI: investorrelations@vanlanschotkempen.com About Van Lanschot ADAPT, SEK, ADAPTEO OYJ, 50, 100, 50 AM1S, SEK, AHLSTROM-MUNKSJO OYJ, 33, 40, 33 LATOB, SEK, INVESTMENT AB LATOUR-B SHS, 50, 60, 50 NXTMSTR, SEK, NEXSTIM OYJ-RTS, 100, 100, 100 Awards · Careers · Information and History · Investor Relations · News @ IBKR · Press and Media Nexstim Oyj. Aktieägarna i Investor har historiskt fått en imponerande avkastning, även De Livsdal investor relations Delarka Börskurs Nexstim 0.07 EUR +1.54%. This company is followed by 4150 investors.